USPL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.968000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.894600E-01
Normal-vs-Stage2
3.908800E-01
Normal-vs-Stage3
2.643400E-01
Normal-vs-Stage4
4.643800E-01
Stage1-vs-Stage2
3.079000E-01
Stage1-vs-Stage3
7.468000E-02
Stage1-vs-Stage4
8.624400E-01
Stage2-vs-Stage3
8.015700E-02
Stage2-vs-Stage4
2.580000E-01
Stage3-vs-Stage4
1.442640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.025600E-01
Normal-vs-AfricanAmerican
3.744000E-01
Normal-vs-Asian
3.239400E-01
Caucasian-vs-AfricanAmerican
6.907000E-01
Caucasian-vs-Asian
1.368570E-01
AfricanAmerican-vs-Asian
4.735800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.945200E-01
Normal-vs-Female
4.017200E-01
Male-vs-Female
8.123600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.926000E-01
Normal-vs-Age(41-60Yrs)
4.764800E-01
Normal-vs-Age(61-80Yrs)
3.675600E-01
Normal-vs-Age(81-100Yrs)
3.304800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.519400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.922400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.051160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.621470E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.059730E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.459600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.418200E-01
Normal-vs-Daily Drinker
3.504600E-01
Normal-vs-Weekly Drinker
3.503600E-01
Normal-vs-Occasional Drinker
4.343800E-01
Normal-vs-Social Drinker
4.730200E-01
Non Drinker-vs-Daily Drinker
8.695000E-01
Non Drinker-vs-Weekly Drinker
9.001000E-01
Non Drinker-vs-Occasional Drinker
9.282000E-02
Non Drinker-vs-Social Drinker
4.887900E-02
Daily Drinker-vs-Weekly Drinker
9.846800E-01
Daily Drinker-vs-Occasional Drinker
1.613640E-01
Daily Drinker-vs-Social Drinker
9.335700E-02
Weekly Drinker-vs-Occasional Drinker
1.845840E-01
Weekly Drinker-vs-Social Drinker
1.189830E-01
Occasional Drinker-vs-Social Drinker
6.328800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.509600E-02
Normal-vs-Grade 2
2.720600E-03
Normal-vs-Grade 3
6.821900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.004000E-01
Grade 1-vs-Grade 3
7.702200E-01
Grade 1-vs-Grade 4
3.509600E-02
Grade 2-vs-Grade 3
7.950800E-01
Grade 2-vs-Grade 4
2.720600E-03
Grade 3-vs-Grade 4
6.821900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.588400E-01
Normal-vs-NonDiabetic
4.005600E-01
Diabetic-vs-NonDiabetic
2.178000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.693600E-01
Normal-vs-NoPancreatitis
3.774000E-01
Pancreatitis-vs-NoPancreatitis
1.623830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.059800E-01
Normal-vs-N1
3.906400E-01
N0-vs-N1
6.675600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.825400E-01
Normal-vs-TP53-NonMutant
4.018600E-01
TP53-Mutant-vs-TP53-NonMutant
6.672400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
